Schizophrenia/Psychosis

Renewed interest and emerging systematic data have highlighted the frequency and pattern of catatonic presentations in psychiatric and medical settings, including in critical illness.

The results of a phase 3 trial demonstrated significant benefit over placebo.

A psychiatrist's chess game with his patient didn't go the way he expected.

The therapist "goes underwater" with the patient to find what lies in her mind.

Recent findings suggest metabolic abnormalities may be independent of the effects of antipsychotics.

What’s the optimal approach for patients with treatment-resistant schizophrenia?

The Psychiatric Transition Program at the Naval Medical Center in San Diego is a specialized first-episode psychosis program that provides coordinated specialty care to active-duty service members with serious mental illness.

During the past 5 years, new insights into the pathophysiological processes that underlie schizophrenia have been revealed. Here's a quick update.

Can dietary supplementation decrease the risk of transition to psychosis?

To augment or not to augment? That is the question.

The nightmarish reality of psychosis is vividly detailed by Deborah Danner, a woman with self-described schizophrenia, recently shot to death by a New York City policeman.

Are antipsychotics associated with an increased risk of breast cancer?

A recent meta-analysis shows this agent is useful in the prevention and treatment of antipsychotic-induced weight gain.

A “high-tech” approach to relapse prevention in patients with schizophrenia.

Can't keep up with the literature? Here's some help.

With antipsychotics, my once-brilliant child can again speak, write, read, and maintain hygiene and has regained motor functioning.

A recent meta-analysis shows this adjunctive agent reduces residual symptoms of psychopathology as well as body weight.

The year 2016 marks a critical time in our understanding of and approaches to treating schizophrenia spectrum disorders.

Is inflammation a cause or consequence of illness in schizophrenia?

The supposed “epidemic” of mental illness turns out to be mostly a myth in the US adult population, 2000-2015.

What an exciting time to be involved in understanding and providing care for people with schizophrenia spectrum disorders!

Psychiatrists who treat patients with psychosis in institutional, community, and crisis settings provide evaluations and medication management, but rarely consider psychotherapeutic interventions. However, such interventions can be critical in recovery.

Culture-the way people make meaning and live their lives in particular social worlds-matters in psychosis. The authors explore how a patient's cultural background should influence the way clinicians think about treatment and care.

The authors discuss the clinical implications of the changes in the DSM-5 section on schizophrenia spectrum and other psychotic disorders.

A review of the distinction between depressive and psychotic symptom domains, current knowledge about the etiology and neurobiology of depression and psychosis, and how this knowledge can inform the treatment of patients with features of both.

It’s not health care expenses that are driving up costs.

Are you aware of this newly identified risk factor for suicide?

This hormone-based therapy shows promise for older women with refractory symptoms.

The authors examine the literature on "quality of life" and how antipsychotics improve that for patients with schizophrenia.